Physician profile
Richard Marc Spiro
NPI 1790753622
$1,466.93
in general payments reported to CMS, 2019-2025
11 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $581 · 2021: $59.87 · 2022: $66.06 · 2023: $136 · 2024: $334 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $500.00 | 2020 | |
| Innovation Technologies INC | $259.68 | 2023-2025 | Irrisept |
| Si-Bone, INC. | $181.62 | 2019-2020 | |
| Medtronic, INC. | $146.14 | 2021-2023 | Catalyft Pl Expandable Interbody System, Anatomic Peek Ptc Cervical Fusion System, Strata |
| Elekta, INC. | $145.47 | 2025 | Leksell Gamma Knife Icon |
| Globus Medical, INC. | $104.30 | 2024 | Excelsius Deformity |
| Abbott Laboratories | $45.16 | 2022 | |
| Stryker Corporation | $33.19 | 2024 | Duramatrix |
| Amgen INC. | $18.50 | 2023 | Repatha |
| Sanara Medtech INC. | $17.03 | 2024 | Celleraterx |
| Novo Nordisk INC | $15.84 | 2023 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Spiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.